Aetna Inc (AET) Shares Bought by Piedmont Investment Advisors LLC

Piedmont Investment Advisors LLC lifted its position in shares of Aetna Inc (NYSE:AET) by 1.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 87,862 shares of the company’s stock after buying an additional 884 shares during the period. Piedmont Investment Advisors LLC’s holdings in Aetna were worth $13,971,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Global X Management Co. LLC increased its holdings in Aetna by 7.8% in the 2nd quarter. Global X Management Co. LLC now owns 7,828 shares of the company’s stock valued at $1,189,000 after purchasing an additional 569 shares in the last quarter. Sigma Planning Corp increased its holdings in Aetna by 2.6% in the 2nd quarter. Sigma Planning Corp now owns 2,702 shares of the company’s stock valued at $410,000 after purchasing an additional 69 shares in the last quarter. Wedbush Securities Inc. increased its holdings in Aetna by 1.4% in the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock valued at $574,000 after purchasing an additional 52 shares in the last quarter. QV Investors Inc. increased its holdings in Aetna by 4.8% in the 2nd quarter. QV Investors Inc. now owns 108,084 shares of the company’s stock valued at $16,410,000 after purchasing an additional 4,940 shares in the last quarter. Finally, LMR Partners LLP acquired a new stake in Aetna in the 2nd quarter valued at $1,569,000. Institutional investors and hedge funds own 88.01% of the company’s stock.

Aetna Inc (AET) opened at $181.57 on Tuesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53. Aetna Inc has a 12-month low of $116.04 and a 12-month high of $192.37. The company has a market cap of $59,601.46, a PE ratio of 17.90, a PEG ratio of 1.67 and a beta of 0.61.

Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping the consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. During the same quarter last year, the company posted $2.07 earnings per share. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. research analysts forecast that Aetna Inc will post 9.78 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, January 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.10%. Aetna’s payout ratio is 37.04%.

In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares in the company, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Several analysts recently issued reports on AET shares. Piper Jaffray Companies reiterated a “hold” rating and issued a $187.00 price target on shares of Aetna in a report on Friday, November 3rd. Zacks Investment Research downgraded Aetna from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Argus downgraded Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price for the company. in a research note on Wednesday, December 6th. BMO Capital Markets raised their target price on Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a research note on Friday, October 27th. Finally, Cantor Fitzgerald downgraded Aetna from an “overweight” rating to a “neutral” rating in a research note on Thursday, October 26th. Twelve research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $175.19.

TRADEMARK VIOLATION WARNING: This report was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this report on another site, it was illegally stolen and republished in violation of United States and international copyright laws. The original version of this report can be read at https://stocknewstimes.com/2017/12/12/aetna-inc-aet-shares-bought-by-piedmont-investment-advisors-llc.html.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply